Promising Approaches to Preventing Weight Loss and Improving Appetite in Lung Cancer Patients

Published on

Topics include: Treatments

Cancer cachexia, weakness and wasting of the body due to cancer, can be a serious issue for lung cancer patients. And medical experts, such as Dr. Phillip Bonomi at Rush Medical Center in Chicago, Illinois, talked with Andrew Schorr on location at the World Conference on Lung Cancer (WCLC) in Denver, Colorado about the newest FDA-approved drug, anamorelin.  Anamorelin shows promise in preventing weight loss, increasing muscle mass, and in some studies, even showed indications of improving fatigue symptoms.  Watch as Dr. Bonomi expounds on this extremely important breakthrough for lung cancer patients.

View more programs featuring

Produced in association with and

Related Programs

The Bureaucracy of Lung Cancer: Are Approval Delays Costing Lives?

From the International Association for the Study of Lung Cancer World Conference in Denver, experts discuss the "autobahn of oncology" concept: high speed regulatory administration with low fatalities.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on September 10, 2015